Qiming U.S. Ventures Management

Qiming U.S. Ventures Management as of Sept. 30, 2025

Portfolio Holdings for Qiming U.S. Ventures Management

Qiming U.S. Ventures Management holds 4 positions in its portfolio as reported in the September 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Tourmaline Bio (TRML) 63.8 $36M 742k 47.83
Korro Bio (KRRO) 31.7 $18M 368k 47.89
Jasper Therapeutics Com New (JSPR) 4.0 $2.2M 929k 2.38
Kezar Life Sciences Com New (KZR) 0.6 $323k 83k 3.90